SC
SRRA

Steven Cohen’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Steven Cohen’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-42,656
Closed -$2.92M – 1618
2019
Q1 		$2.92M Hold
42,656
– – 0.01% 654
2018
Q4 		$2.25M Buy
42,656
+2,500
+6% +$160K 0.01% 699
2018
Q3 		$2.73M Hold
40,156
– – 0.01% 716
2018
Q2 		$4.75M Sell
40,156
-9,844
-20% -$988K 0.02% 623
2018
Q1 		$4.14M Buy
50,000
+43,750
+700% +$4.96M 0.02% 617
2017
Q4 		$933K Sell
6,250
-31,250
-83% -$3M ﹤0.01% 809
2017
Q3 		$2.33M Buy
+37,500
New +$2.2M 0.01% 660

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Steven Cohen's SRRA Position: Q2 2019 in Review

Steven Cohen sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2019, closing a stake of 42,656 shares — an estimated $2.92M sold.

Steven Cohen first reported a position in SRRA in Q3 2017 and held it in 7 quarters. The position peaked at $4.75M in Q2 2018. 49 funds tracked by Wall St. Rank hold SRRA as of Q2 2019.

  • Steven Cohen reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Steven Cohen sold 42,656 Sierra Oncology, Inc. Common Stock shares in Q2 2019, an estimated $2.92M.
  • Steven Cohen first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
  • Steven Cohen's Sierra Oncology, Inc. Common Stock position peaked at $4.75M in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2019.

Based on Point72 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.